Article Versions Notes

Pellegrino M, Rizza P, Donà A, Nigro A, Ricci E, Fiorillo M, Perrotta I, Lanzino M, Giordano C, Bonofiglio D, et al. FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer. Cancers. 2019; 11(12):1858. https://doi.org/10.3390/cancers11121858

Pellegrino, Michele, Pietro Rizza, Ada Donà, Alessandra Nigro, Elena Ricci, Marco Fiorillo, Ida Perrotta, Marilena Lanzino, Cinzia Giordano, Daniela Bonofiglio, and et al. 2019. "FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer" Cancers 11, no. 12: 1858. https://doi.org/10.3390/cancers11121858

Pellegrino, M., Rizza, P., Donà, A., Nigro, A., Ricci, E., Fiorillo, M., Perrotta, I., Lanzino, M., Giordano, C., Bonofiglio, D., Bruno, R., Sotgia, F., Lisanti, M. P., Sisci, D., & Morelli, C. (2019). FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer. Cancers, 11(12), 1858. https://doi.org/10.3390/cancers11121858